The partnership brings administration of the awards under ISID, providing consistent support and broader promotion across the global dermatology research community. This is especially significant for the Asia-Pacific region, which previously had limited administrative infrastructure for the awards program. The goal is to ensure exceptional science from all ISID regions receives the visibility and support it deserves.

The ISID-LEO Foundation Awards recognize outstanding scientists whose work represents an extraordinary contribution to skin research and has the potential to pave the way for new and improved treatments for skin diseases. Three awards of $100,000 each are given annually — one in each global region: Americas, EMEA (Europe, Middle East, Africa), and Asia-Pacific.

What This Means for Applicants

• Greater visibility within the global investigative dermatology community through SID, ESDR, and Asian society channels
•  Enhanced networking opportunities and potential collaborations across ISID regions
• Consistent application support and communication throughout the evaluation process
• ISID-LEO Foundation Alumni status, connecting you with a growing international cohort of emerging leaders in skin science

2026 Americas Region—Inaugural Cycle

Applications open: Monday, February 2, 2026 (Midnight ET)
Applications close: Saturday, February 28, 2026 (Midnight ET)
Winner notified: Early April 2026

Applications are evaluated by an independent Global Review Panelof internationally recognized experts representing societies across all three regions, ensuring unbiased assessment to the highest scientific standards.
Eligibility at a Glance

Self-nominees must:

• Be working within the Americas region
• Be between 30 and 40 years of age at the time of award (with provisions for career breaks, including parental leave)
• Be active scientists within skin-related research
• Demonstrate at least 5 peer-reviewed first author, co-first author, or last author publications in skin-related research

Application Requirements

• Comprehensive CV
• Letter of recommendation from a senior colleague/collaborator/mentor
• Overview of current and previous independent funding (up to 3 years)
• List of top-10 peer-reviewed publications
• Paragraph on previous research achievements
• Paragraph on future research vision

Learn More + Apply

About ISID

The International Societies for Investigative Dermatology (ISID) is a global alliance of dermatology research societies dedicated to advancing the science of skin health and disease. ISID members include the Society for Investigative Dermatology (SID), the European Society for Dermatological Research (ESDR), and societies from Taiwan, Korea, Japan, Singapore, and Australasia. Together, these organizations support thousands of researchers, clinicians, and trainees working to unlock discoveries that improve human health. Learn more at isiderm.org.

About the LEO Foundation

The LEO Foundation is an independent, commercial foundation that aims to improve the lives of people with skin diseases through research, education, and innovation. Since establishing the LEO Foundation Awards in 2008, the Foundation has recognized approximately 40 exceptional young scientists worldwide. Based in Denmark, the Foundation is committed to continually promoting and advancing skin research, strengthening the pipeline of excellent dermatology researchers globally. Learn more at leo-foundation.org.

The post ISID and LEO Foundation Partner to Expand Global Reach of Early-Career Awards appeared first on SID.

The successful candidate will work with a collaborative group of 23 faculty, 16 residents, 1 fellow, and dedicated staff within the department of dermatology.
In addition, the candidate will be expected to be part of UCI Skin, UC Irvine’s funded P30 Skin Disease Research Center, and participate in joint events which include the UCI Skin club which meets weekly, the annual Skin Symposium, and UCI Skin’s T32 training grant retreats and activities.

Criteria for the Professor of Clinical “X” Series: All ranks will be expected to have a record of substantial research; lead or have a significant intellectual and substantive contribution to a research program and/or be involved in other creative activities that would be expected to position the candidate, over time, to be a recognized academic leader in their field and obtain peer-reviewed funding. Creative activity may be highly integrated into clinical activities. To achieve this goal, the incumbent will be expected to conduct substantial research; provide patient care or conduct patient oriented research; teach fellows, residents, and medical students; and perform public and University service. Positions and the extent of protected time are dependent upon funding.

Rank will be determined based on qualifications and experience. Appointment to this position is eligible for annual renewal and provides membership to the Academic Senate.

A link to a full description of Clinical X series is provided for your review:
Clinical X Professor – see: http://www.ucop.edu/academic-personnel-programs/_files/apm/apm-275.pdf

For more information about the Department of Dermatology, please visit: Dermatology: https://medschool.uci.edu/research/clinical-departments/dermatology
What We Offer:
• A competitive compensation package commensurate with experience.
• Comprehensive benefits including medical, dental, & vision.
• Generous vacation time and professional development support.
• A desirable location in beautiful Orange County. Residents enjoy a high standard of living, great schools, limitless year-round recreational and outdoor
activities, world-famous beaches, the arts, sports, an abundance of great cuisine, and cultural diversity.
Application Procedure: Interested candidates should apply through UC Irvine’s RECRUIT system located at: https://recruit.ap.uci.edu/JPF09973

QUALIFICATIONS:
Basic qualifications (required at time of application) Candidates must possess a MD, PhD, or MD/PhD degree in the field of Dermatology or equivalent.

About UC Irvine:
The University of California, Irvine is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, age, protected veteran status, or other protected categories covered by the UC anti-discrimination policy.
As a condition of employment, the finalist will be required to disclose if they are subject to any final administrative or judicial decisions within the last seven years determining that they committed any misconduct.
“Misconduct” means any violation of the policies or laws governing conduct at the applicant’s previous place of employment, including, but not limited to, violations of policies or laws prohibiting sexual harassment, sexual assault, or other forms of harassment or discrimination, as defined by the employer.
UC Sexual Violence and Sexual Harassment Policy
UC Anti-Discrimination Policy for Employees, Students and Third Parties
APM – 035: Affirmative Action and Nondiscrimination in Employment.
As a University employee, you will be required to comply with all applicable University policies and/or collective bargaining agreements, as may be amended from time to time. Federal, state, or local government directives may impose additional requirements.

https://recruit.ap.uci.edu/JPF09973

04/24/2026

https://www.sidnet.org/wp-content/uploads/2026/01/JPF09973-Assistant-or-Associate-Professor-Dermatology-Clin-X-Series-2.pdf

The post Assistant or Associate Professor, Dermatology (Clin X Series) appeared first on SID.

Learn more here: https://www.langerhans.org

SID supports and collaborates with investigative dermatology societies and research organizations worldwide. Explore upcoming meetings and conferences hosted by our partner organizations and fellow skin science communities.

Meeting details subject to change. Visit each organization’s website for the most current information and registration details.

The post October 18-21, 2027: 19th International Workshop of Langerhans Cells and Related Myeloid Cells of the Skin appeared first on SID.

Review and scoring will take place from Saturday, January 17, through Sunday, February 1, with scores tabulated during the week of February 2. The Committee on Scientific Programs chairs will then meet in person to review submissions and their scores, determining which abstracts will be selected for oral presentations and poster sessions. The chairs will also assess travel grant applications and select awardees during this time.

Acceptance notifications will be sent to the contacts identified in abstract submissions during the week of February 16. Travel grant recipients will be notified no later than February 27.

Late-breaking abstract submissions open on Monday, March 2, for time-sensitive, high-impact research that was not available by the regular deadline. Review the late-breaking criteria and submit here. The late-breaking submission window closes March 20, with acceptance notifications going out during the week of April 6.

All accepted abstracts will be available electronically for viewing no later than May 1 and will be published in a late summer/early fall edition of the Journal of Investigative Dermatology (JID).

Should you have any questions regarding the abstract process, please email abstracts@sidnet.org for additional support.

We look forward to seeing you in Chicago this May.

The post What’s Next in the Abstract Review Process appeared first on SID.

The College of Medicine offers state-of-the-art programs in medical education, groundbreaking research opportunities, and leading-edge patient care, along with an active Medical Student Training Program. With 14 core faculty, and 9 residents, the Department of Dermatology is a comprehensive academic clinical department with established community partnerships in a wide variety of areas. Specifically, for skin cancer, there is a strong record of basic-translational/clinical research in melanoma and NMSC. The Dermatology Department is an integral component of the UACC Skin Cancer Institute (SCI) with a unique approach to address the high rate of skin cancer in the state of Arizona and beyond. Clinicians, scientists, epidemiologists, engineers, and pharmacists collaborate closely in a transdisciplinary manner, resulting in over 20 years of successful funding across multiple disciplines. Another feature that highlights the uniqueness of this program is the collaborative culture and supportive environment of the Department of Dermatology.

The incumbent will work collaboratively with the leaders of the College and Banner – University Medicine to further the tripartite mission of achieving excellence in clinical care, education, and individual and team-based research to position the department for continued growth through innovation.

Founded in 1976, the University of Arizona Cancer Center (UACC) is one of only 57 NCI-designated Comprehensive Cancer Centers, a distinction that places it among the elite top tier of cancer centers nationwide. Entering an exciting new era of strategic growth and active transformation under the helm of Dan Theodorescu, MD, PhD, the UACC is poised for unparalleled success across all of its missions. Skin Cancer has been identified as one of the priority focus areas for UACC, which provides important support for this area of investigation.

The University of Arizona College of Medicine-Tucson is the anchor of the University of Arizona Health Sciences campus. The College inspires and trains individuals to become exemplary physicians, scientists and leaders who are life-long learners and inquisitive scholars. We embrace professionalism, innovation, and collaboration to optimize health and health care for all. The University of Arizona Health Sciences embodies the University’s priorities of engagement, partnership, innovation, and synergy in its world-class academic and research initiatives, with clinical facilities throughout Greater Tucson. The campus also houses the UA Colleges of Public Health, Pharmacy, and Nursing, as well as multiple Centers of Excellence.

For full position details, please see the job listing on the UA Employment website.

https://arizona.csod.com/ux/ats/careersite/4/home/requisition/24502?c=arizona&sq=req24502

03/31/2026

The post Assistant/Associate/Full Professor, Dermatology – University of Arizona, Tucson, AZ appeared first on SID.

Responsibilities and Duties:
We are seeking investigative dermatology and cutaneous biology researchers with demonstrated accomplishments in an area related to skin immunobiology, cell biology and skin disease. The candidate may be working in areas such as: 1) biologic pathway interactions between host epithelium, including hair follicle biology, immune system, and microbes, and/or 2) translational or clinical informatics research with diagnostic, prognostic or therapeutic applications. M.D. Ph.D., or M.D. with significant research training is preferred.

Assistant Professor level candidates should have a demonstrated record of success in multiple venues with substantial potential to obtain external funding. Candidates at the Associate or Full Professor levels should have robust and active research programs and demonstrable national or international reputations, respectively with a history of mentorship and leadership.

Interested candidate should forward a cover letter, CV, statement of research interests and names of 3 references in a single pdf file to maryann.bolden@uhhospitals.org.

06/30/2026

The post Dermatology Physician-Scientist appeared first on SID.

Welcome to the 2026 SID Annual Meeting. My presidential theme this year—Appreciation—celebrates the opportunities and dedication of our global skin research community that has led to the remarkable diversity, creativity, and achievements that define skin biology today. Whether you are an academic investigator, a practicing clinician, an industry innovator, a patient advocate, or part of the infrastructure that supports research in dermatology, your unique perspective enriches our field and strengthens our shared mission to improve skin health for all.

This meeting offers an exceptional forum to explore complementary emergent data spanning basic, translational, and clinical research. By bringing together ideas and discoveries from multiple disciplines and methodologies, we open new avenues for collaboration and foster a deeper understanding of the complexities of skin biology and dermatologic diseases. The proximity of cutting-edge findings presented here enables us to make connections that may otherwise take months—or years—to fully realize.

Importantly, our annual SID meeting represents the premiere opportunity for convergence of ideas that support the acceleration of discovery. When we integrate insights from bench science, clinical observation, therapeutic development, and lived patient experience, we create the conditions for more impactful research and faster innovation. While including updates on the exciting therapeutics in development today, the research presented in our annual meeting has been the foundation for tomorrow’s advances. The SID community has long demonstrated that breakthroughs arise when we learn from one another, challenge assumptions, and work collectively toward solutions. This year, I seek to highlight the many positive contributions from our members that have made our successes possible.

As we gather in 2026, I invite you to engage fully—ask questions, share your expertise, and appreciate the contributions of colleagues across every sector. Your participation strengthens our Society and advances a culture of mutual respect, curiosity, and collaboration. Thank you for being part of this vibrant international community and for your continued commitment to advancing investigative dermatology. I look forward to an inspiring and productive meeting ahead.

The post 2026 SID Annual Meeting: President’s Welcome Message appeared first on SID.

About the Role

The JID Editor serves a five-year term from June 1, 2027, through May 31, 2032. The journal is a top-ranked publication in dermatology with an Impact Factor of 5.7 (2024), and the Editor plays a critical role in advancing the communication of skin science globally.

The ideal candidate is a dynamic, recognized investigator with a strong commitment to scientific communication. Responsibilities include selecting content for publication, developing a strategic vision for the journal, and recruiting an effective editorial board to reflect the breadth of investigative dermatology.

Co-Editor applications are welcome.

Editorial Operations

Editorial operations have been centered in Chapel Hill, North Carolina, since 2002, though recent Editors have been based in locations including Geneva, Switzerland; Dallas; Boston; St. Louis; and Vienna, Austria. Manuscript submission, review, and production are managed through an online system that facilitates remote collaboration and rapid review.

Application Process

An Ad-Hoc committee including both SID and ESDR members will review submitted proposals and interview candidates. Current JID Editor Erwin Tschachler, MD, and Executive Managing Editor Elizabeth Blalock welcome informal discussions with prospective applicants. Contact Ms. Blalock at Blalock@sidnet.org to arrange a conversation.

Key Deadlines

• February 16, 2026: Letters of Intent due
• April 1, 2026: Full proposals due
• April 2026: Virtual interviews with final candidates
• May 13, 2026: Next JID Editor announced
• June 1, 2026–May 31, 2027: Editor transition period

How to Apply

Interested individuals and those wishing to nominate colleagues should contact the SID Office for application requirements:

Society for Investigative Dermatology

2027 JID Editor Search Committee
Attn: Rebecca Minnillo, DM/MPA
526 Superior Avenue, East, Suite 340
Cleveland, OH 44114 USA

Tel: 216-579-9300, ext. 305
Email: minnillo@sidnet.org

Contact Dr. Minnillo for information on the Letter of Intent.

Download the full job description (PDF)

The post Applications Open for Journal of Investigative Dermatology Editor appeared first on SID.

Key Dates to Remember

• November 10, 2025: Submissions open
• January 13, 2026, 11:59 p.m. EST: Submission deadline
• Mid-February 2026: Notifications sent
• March 2-20, 2026: Late-breaking abstract window (see note below)

Submission Requirements at a Glance

New research only

The material must not have been published prior to submission of the abstract or presented at any conference prior to the date of presentation at the Annual Meeting.

One abstract per presenting author

You can only submit one abstract as the presenting author, though you may be listed as a co-author on multiple submissions

2,300-character limit

This includes your title, authors, institutions, abstract body, and all spaces.

Results must be included

Abstracts stating “Results will be discussed” or “Data will be presented” will not be accepted.

No AI-generated text

Text generated by artificial/augmented intelligence may not be included. However, research that used ML/AI tools for data acquisition or analysis is eligible for submission.
$50 submission fee
Payment is required online at the time of submission.

How Abstracts Are Reviewed

After the January 13 deadline, all abstracts are reviewed by the SID Committee on Scientific Programs plus two independent reviewers for each category topic. Reviews are conducted without knowing the identity of authors (blind review).

Top-rated abstracts will be selected for oral presentations (Plenary, Concurrent Mini-Symposium, or e-Poster Talk), while others will be featured in poster sessions

Travel Grants: Apply While You Submit

Travel grants are available for residents, fellows, students, lab technicians, and junior faculty. Awards are made to underrepresented minorities, investigators from developing countries, and on a merit basis.

The application is integrated into Step 3 of the abstract submission process, and the deadline is the same as the abstract deadline: January 13.

What About Late-Breaking Abstracts?

Late-breaking abstract submissions open March 2-20 for “unpublished high-impact research results that were not available by the regular abstract submission deadline and merit special consideration” – such as groundbreaking clinical trial results.

Important: The late-breaking window is not an extension of the regular deadline, and abstracts not accepted during the main review are not eligible for resubmission. 

Publication of Accepted Abstracts

All accepted abstracts will be published in the August 2026 supplement of the Journal of Investigative Dermatology (JID). An unofficial version will also be available on the SID website in early May.

Ready to Submit?

Submit Your Abstract

View Full Guidelines & Timeline


Explore Abstract Categories

Questions? Contact abstracts@sidnet.org.

The post What to Know Before Submitting Your Abstract to the 2026 SID Annual Meeting appeared first on SID.

Planning to convene your board, host a symposium, or gather colleagues during the 2026 SID Annual Meeting in Chicago? Associate group meeting space reservation requests are now open.

What’s Available

Groups may reserve private meeting space at the Hilton Chicago during the SID Annual Meeting (May 12–16, 2026). Reservations include:

• Dedicated meeting room for your selected time slot
• Optional audio-visual equipment package
• Two complimentary registrations for administrative staff
• Access to hotel catering and room setup services

Space is limited and assigned on a first-come, first-served basis.

Key Dates

• Request deadline: April 1, 2026
• Reservation confirmations begin: Mid-December 2025
• Invoices issued: Beginning January 2026

How to Reserve

Review available time slots, pricing, and reservation details, then submit your request online:

Reserve Meeting Space for SID 2026

Questions?

Contact Deb Kovacs at kovacs@sidnet.org for assistance with your reservation request.

The post Associate Group Meeting Space Requests Now Open for SID 2026 appeared first on SID.